Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT) (REPEAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01352338
Recruitment Status : Completed
First Posted : May 11, 2011
Last Update Posted : February 26, 2016
Celgene Corporation
Information provided by (Responsible Party):
I.S. Nijhof, UMC Utrecht